Journal of Neurology

, Volume 254, Issue 1, pp 38–45 | Cite as

The effect of age of onset of PD on risk of dementia

  • D. Aarsland
  • J.T. Kvaløy
  • K. Andersen
  • J.P. Larsen
  • M.X. Tang
  • A. Lolk
  • P. Kragh-Sørensen
  • K. Marder
ORIGINAL COMMUNICATION

Abstract

Background

Dementia occurs in the majority of patients with Parkinson’s disease (PD). Late onset of PD has been reported to be associated with a higher risk for dementia. However, age at onset (AAO) and age at baseline assessment are often correlated. The aim of this study was to explore whether AAO of PD symptoms is a risk factor for dementia independent of the general effect of age.

Methods

Two community-based studies of PD in New York (n = 281) and Rogaland county, Norway (n = 227) and two population-based groups of healthy elderly from New York (n = 180) and Odense, Denmark (n = 2414) were followed prospectively for 3–4 years and assessed for dementia according to DSM-IIIR. All PD and control cases underwent neurological examination and were followed with neurological and neuropsychological assessments. We used Cox proportional hazards regression based on three different time scales to explore the effect of AAO of PD on risk of dementia, adjusting for age at baseline and other demographic and clinical variables.

Findings

In both PD groups and in the pooled analyses, there was a significant effect of age at baseline assessment on the time to develop dementia, but there was no effect of AAO independent of age itself. Consistent with these results, there was no increased relative effect of age on the time to develop dementia in PD cases compared with controls.

Interpretation

This study shows that it is the general effect of age, rather than AAO that is associated with incident dementia in subjects with PD.

Keywords

Parkinson’s disease dementia age at onset age 

References

  1. 1.
    (1987) Diagnostic and Statistical Manual of Mental Disorders. Third edition, revised. American Psychiatric Association, Washinton D.C.Google Scholar
  2. 2.
    Andersen K, Nielsen H, Lolk A, Andersen J, Becker I, Kragh-Sorensen P (1999) Incidence of very mild to severe dementia and Alzheimer’s disease in Denmark: the Odense Study. Neurology 52:85–90PubMedGoogle Scholar
  3. 3.
    Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59:102–112PubMedCrossRefGoogle Scholar
  4. 4.
    Cox SM, Stefanova E, Johnsrude IS, Robbins TW, Owen AM (2002) Preference formation and working memory in Parkinson’s disease and normal ageing. Neuropsychologia 40:317–326PubMedCrossRefGoogle Scholar
  5. 5.
    Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2:229–237PubMedCrossRefGoogle Scholar
  6. 6.
    Fahn S, R.L. E, Committee. MotUD (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DM, A. L (eds) Recent development in Parkinson’s disease. MacMillan Health Care Information, Florham Park, NJ, pp 153–163Google Scholar
  7. 7.
    Folstein M, S.E. F, P.R. M (1975) A practical method for grading the mental state of patients for the clinican. Journal of Psychiatric Research 12:189–198PubMedCrossRefGoogle Scholar
  8. 8.
    Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson’s disease. J Neurol 249:138–145PubMedCrossRefGoogle Scholar
  9. 9.
    Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study. Brain 127:550–560Google Scholar
  10. 10.
    Gibb WR, Lees AJ (1988) A comparison of clinical and pathological features of young- and old-onset Parkinson’s disease. Neurology 38:1402–1406PubMedGoogle Scholar
  11. 11.
    Graham JM, Sagar HJ (1999) A data-driven approach to the study of heterogeneity in idiopathic Parkinson’s disease: identification of three distinct subtypes. Mov Disord 14:10–20PubMedCrossRefGoogle Scholar
  12. 12.
    Hely MA, Morris JG, Reid WG, O’Sullivan DJ, Williamson PM, Broe GA, Adena MA (1995) Age at onset: the major determinant of outcome in Parkinson’s disease. Acta Neurol Scand 92:455–463PubMedCrossRefGoogle Scholar
  13. 13.
    Hietanen M, Teravainen H (1988) The effect of age of disease onset on neuropsychological performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:244–249PubMedGoogle Scholar
  14. 14.
    Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049PubMedCrossRefGoogle Scholar
  15. 15.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRefGoogle Scholar
  16. 16.
    Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, Spokes EG (2000) A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54:1596–1602PubMedGoogle Scholar
  17. 17.
    Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R (1995) Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology 45:1691–1696PubMedGoogle Scholar
  18. 18.
    Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson’s disease. J Neural Transm 109:329–339PubMedCrossRefGoogle Scholar
  19. 19.
    Larsen JP, Dupont E, Tandberg E (1994) Clinical diagnosis of Parkinson’s disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 89:242–251PubMedCrossRefGoogle Scholar
  20. 20.
    Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K (2005) Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol 62:467–472PubMedCrossRefGoogle Scholar
  21. 21.
    Levy G, Marder K (2003) Prevalence, incidence, and risk factors for dementia in Parkinson’s disease. In: Bedard MA, Agid Y, Chouinard S, Fahn S, Korczyn A, Lesperance P (eds) Mental and behavioral dysfunction in movement disorders. Humana Press, Totowa, N.J., p 259–270CrossRefGoogle Scholar
  22. 22.
    Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K (2002) Combined effect of age and severity on the risk of dementia in Parkinson’s disease. Ann Neurol 51:722–729PubMedCrossRefGoogle Scholar
  23. 23.
    Levy G, Tang MX, Louis ED, Cote LJ, Alfaro B, Mejia H, Stern Y, Marder K (2002) The association of incident dementia with mortality in PD. Neurology 59:1708–1713PubMedGoogle Scholar
  24. 24.
    Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348PubMedCrossRefGoogle Scholar
  25. 25.
    Marder K, Tang MX, Cote L, Stern Y, Mayeux R (1995) The frequency and associated risk factors for dementia in patients with Parkinson’s disease. Arch Neurol 52:695–701PubMedGoogle Scholar
  26. 26.
    Mattis S (1976) Dementia Rating Scale. In: Bellak L, TB K (eds) Geriatric psychiatry. A handbook for psychiatrists and primary care physicians. Grune & Stratton, New York, p 108–121Google Scholar
  27. 27.
    Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua R, Wilder D, Gurland B, et al. (1995) The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988–1993. Am J Epidemiol 142:820–827PubMedGoogle Scholar
  28. 28.
    McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedGoogle Scholar
  29. 29.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMedGoogle Scholar
  30. 30.
    Reider CR, Halter CA, Castelluccio PF, Oakes D, Nichols WC, Foroud T (2003) Reliability of reported age at onset for Parkinson’s disease. Mov Disord 18:275–279PubMedCrossRefGoogle Scholar
  31. 31.
    Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709PubMedCrossRefGoogle Scholar
  32. 32.
    Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 271:1004–1010PubMedCrossRefGoogle Scholar
  33. 33.
    Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA (1995) The epidemiology of Parkinson’s disease in the county of Rogaland, Norway. Mov Disord 10:541–549PubMedCrossRefGoogle Scholar
  34. 34.
    Tiraboschi R, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal L, Corey-Bloom J (2000) Cholinergic dysfunction in diseases with Lewy bodies. Neurology 54:407–411PubMedGoogle Scholar
  35. 35.
    Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson’s disease. Adv Neurol 53:245–249PubMedGoogle Scholar
  36. 36.
    Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392PubMedCrossRefGoogle Scholar
  37. 37.
    Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56:730–736PubMedGoogle Scholar
  38. 38.
    Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E (1999) Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 14:866–874PubMedCrossRefGoogle Scholar
  39. 39.
    Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942PubMedGoogle Scholar
  40. 40.
    Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: A prospective, community-based study. Ann Neurol 58:773–776PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2007

Authors and Affiliations

  • D. Aarsland
    • 1
    • 2
  • J.T. Kvaløy
    • 4
    • 5
  • K. Andersen
    • 3
  • J.P. Larsen
    • 1
  • M.X. Tang
    • 6
    • 7
    • 8
  • A. Lolk
    • 3
  • P. Kragh-Sørensen
    • 3
  • K. Marder
    • 7
    • 8
    • 9
  1. 1.Norwegian Centre for Movement DisordersStavanger University HospitalStavangerNorway
  2. 2.School of Medicine, University of BergenNorway
  3. 3.Dept. of PsychiatryOdense University HospitalOdenseDenmark
  4. 4.Dept. of Mathematics and Natural SciencesUniversity of StavangerStavangerNorway
  5. 5.Division of Research and Human ResourcesStavanger University HospitalNorway
  6. 6.Dept. of BiostatisticsColumbia UniversityNew YorkUSA
  7. 7.The G.H. Sergievsky CenterColumbia University College of Physicians and SurgeonsNew YorkUSA
  8. 8.The Taub Institute for Alzheimer’s Disease and the Aging BrainNew YorkUSA
  9. 9.Dept. of NeurologyColumbia University College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations